FCC COVID-19 Telehealth Program – Get Started
[dflip id=”32103″][/dflip]
FCC COVID-19 Telehealth Program – Get Started Read More »
[dflip id=”32103″][/dflip]
FCC COVID-19 Telehealth Program – Get Started Read More »
[dflip id=”32098″][/dflip] A. Application Evaluation Process 1. Application Evaluation Metrics The Consolidated Appropriations Act directs
FCC REPORT AND ORDER AND ORDER ON RECONSIDERATION – Round 2 Evaluation Metrics Read More »
[dflip id=”32090″][/dflip] AGENCY: Federal Communications Commission. ACTION: Final rule. SUMMARY: In this document, the Federal
Federal Register – FCC COVID-19 Telehealth Program Read More »
[dflip id=”32084″][/dflip] Media Contact:Katie Gorscakkatie.gorscak@fcc.gov Program Contact:Round2TelehealthApplicationSupport@usac.org For Immediate Release FCC ANNOUNCES ROUND 2 COVID-19
[dflip id=”32078″][/dflip] Before theFEDERAL COMMUNICATIONS COMMISSIONWASHINGTON, D.C. 20554 In the Matter of COVID-19 Telehealth Program
[dflip id=”32072″][/dflip] FCC ADOPTS REPORT AND ORDER TO IMPLEMENT ROUND 2 OF COVID-19 TELEHEALTH PROGRAM
FCC ADOPTS REPORT AND ORDER TO IMPLEMENT ROUND 2 OF COVID-19 TELEHEALTH PROGRAM Read More »
[dflip id=”32066″][/dflip] Telehealth is a way to receive healthcare services remotely through various communication technologies.
What Is Telehealth? Read More »
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing
Respiri (ASX:RSH) receives FDA tick for Wheezo Read More »